I think context is important here - there are many issues with the way covaxin was approved & rolled out- phase 3 data were never published prior to approval (still not published)- this led to lots of vaccine hesitancy - even among HCWs. There were also many issues with the trial
-
-
It's clear that scores of crores of people have not been followed up- which brings up the question as to how this was assessed. And why no control group data have been released. It's worth following commentary from Indian PH experts- there are real concerns about ICMR reporting.
2 replies 0 retweets 3 likes -
And there are real issues about transparency with data release with covaxin - and have been from the start. Its important not to make any judgement on this until the data are fully released.
1 reply 0 retweets 0 likes -
The govt covaxin roll-out has been a scandal. They essentially rolled out a vaccine without phase 3 data (people were asked to consent during roll-out as if they were participating in a trial!). They've been asked to release data repeatedly to win public trust but haven't.
1 reply 0 retweets 1 like -
They are keen to encourage vaccine uptake- but have done so without any transparency, despite the public wanting more information to allay concerns. And they're still going for press release by media, without control groups or scrutiny from the global scientific community.
1 reply 0 retweets 0 likes -
I know many people possibly aren't aware of this context, but there's been a big uproar in India about it for months- without any credible response from govt, or vaccine manufacturers.
0 replies 0 retweets 0 likes -
This Tweet is unavailable.
-
Better, I think- it's also been rolled out far more, as you can see in the limited data provided. I think many were understandably not very happy with taking a vaccine that had not gone through trial.
0 replies 0 retweets 1 like -
This Tweet is unavailable.
-
India has actually been manufacturing and exporting a lot of AZ (they're a key manufacturing hub), so it's more that they may retain doses, rather than them being rerouted.
1 reply 0 retweets 3 likes
Yeah. The case chart (which is likely underreported) looks terrifying. I wouldn't rule out India becoming the highest mortality country, more than a year into the pandemic, even after vaccines were available, and while manufacturing good chunk of global supply. What a tragedy.
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.